Browsing Centre for Oral Immunobiology and Regenerative Medicine by Author "Fortune, F"
Now showing items 1-20 of 34
-
2018 update of the EULAR recommendations for the management of Behçet's syndrome.
Hatemi, G; Christensen, R; Bang, D; Bodaghi, B; Celik, AF; Fortune, F; Gaudric, J; Gul, A; Kötter, I; Leccese, P (2018-06)Several new treatment modalities with different mechanisms of action have been studied in patients with Behçet's syndrome (BS). The aim of the current effort was to update the recommendations in the light of these new data ... -
Adamantiades-Behcet's disease (Behcet's disease) and COVID-19
Zouboulis, CC; van Laar, JAM; Schirmer, M; Emmi, G; Fortune, F; Gul, A; Kirino, Y; Lee, E-S; Sfikakis, PP; Shahram, F (Wiley, 2021-04-29) -
Behcet's disease: do natural killer cells play a significant role?
Petrushkin, H; Hasan, MS; Stanford, MR; Fortune, F; Wallace, GR (2015-03-24) -
Circulating NK cells and their subsets in Behcet's disease
Hasan, MS; Ryan, PL; Bergmeier, LA; Fortune, F (2017-05) -
Circulating NK cells and their subsets in Behçet's disease
Hasan, MS; Ryan, PL; Bergmeier, LA; Fortune, F (Wiley, 2017-05-01)Behçet's disease (BD) is an autoinflammatory, chronic relapsing/remitting disease of unknown aetiology with both innate and acquired immune cells implicated in disease pathogenesis. Peripheral blood natural killer (NK) ... -
Clinical Review: Familial Mediterranean Fever-An Overview of Pathogenesis, Symptoms, Ocular Manifestations, and Treatment
Petrushkin, H; Stanford, M; Fortune, F; Jawad, AS (2016-08) -
DOES EULAR SJOGREN'S SYNDROME PATIENT REPORTED INDEX (ESSPRI)-PAIN MODERATE DAILY ACTIVITY IMPAIRMENT IN PATIENTS WITH PRIMARY SJOGREN SYNDROME?
Yenisoy, Y; Altingoz, EN; Kapusuz, A; Abacar, KY; Tatli, I; Ture-Ozdemir, F; Karacayli, U; Yay, M; Direskeneli, H; Fortune, F (2022) -
Downstream targets of FOXM1: CEP55 and HELLS are cancer progression markers of head and neck squamous cell carcinoma
Waseem, A; Ali, M; Odell, EW; Fortune, F; Teh, MT (2010-07) -
Dysregulation of the suppressor of cytokine signalling 3-signal transducer and activator of transcription-3 pathway in the aetiopathogenesis of Sjogren's syndrome
Vartoukian, SR; Tilakaratne, WM; Seoudi, N; Bombardieri, M; Bergmeier, L; Tappuni, AR; Fortune, F (2014-09) -
FOXM1 Upregulation Is an Early Event in Human Squamous Cell Carcinoma and it Is Enhanced by Nicotine during Malignant Transformation
Gemenetzidis, E; Bose, A; Riaz, AM; Chaplin, T; Young, BD; Ali, M; Sugden, D; Thurlow, JK; Cheong, SC; Teo, SH (2009-03-16) -
Gamma Delta (gamma delta) T Cells and Their Involvement in Behcet's Disease
Hasan, MS; Bergmeier, LA; Petrushkin, H; Fortune, F (2015) -
Genital ulcer severity score and genital health quality of life in Behcet's disease
Senusi, A; Seoudi, N; Bergmeier, LA; Fortune, F (2015-09-22) -
Genital ulcer severity score and genital health quality of life in Behçet's disease
Senusi, A; Seoudi, N; Bergmeier, LA; Fortune, F (BioMed Central, 2015-09-22)Background: Behçet's Disease (BD) is a chronic auto-inflammatory, multisystem relapsing/remitting disorder of unknown aetiology. Oro-genital ulceration is a key feature of the disease and has a major impact on the patients' ... -
Glucocorticoid sensitivity in Behcet's disease
Quax, RAM; van Laar, JAM; van Heerebeek, R; Greiner, K; Ben-Chetrit, E; Stanford, M; Wallace, GR; Fortune, F; Ghabra, M; Soylu, M (2012-11-01) -
Improving morbidity and mortality in peripheral ulcerative keratitis associated with rheumatoid arthritis.
Petrushkin, HJD; Stanford, M; Fortune, F; Jawad, A (2016-01) -
Induction of p53 in keratinocyte cultures treated with Behcet's patient sera
Houacine, S; Kang, A; Parkinson, EK; Wan, H; Fortune, F (John Wiley and Sons, 2020-02-15) -
The influence of oral health and psycho-social well-being on clinical outcomes in Behcet's disease
Senusi, A; Higgins, S; Fortune, F (2018) -
KIR3DL1/S1 Allotypes Contribute Differentially to the Development of Behcet Disease
Petrushkin, H; Norman, PJ; Lougee, E; Parham, P; Wallace, GR; Stanford, MR; Fortune, F (The American Association of Immunologists, Inc., 2019-08-12) -
Management of major organ involvement of Behçet's syndrome: a systematic review for update of the EULAR recommendations.
Ozguler, Y; Leccese, P; Christensen, R; Esatoglu, SN; Bang, D; Bodaghi, B; Çelik, AF; Fortune, F; Gaudric, J; Gul, A (2018-12-01)Objective: To assess the efficacy and safety of treatment modalities for major organ involvement of Behçet's syndrome (BS), in order to inform the update of the EULAR recommendations for the management of BS. Methods: A ... -
Management of skin, mucosa and joint involvement of Behçet's syndrome: A systematic review for update of the EULAR recommendations for the management of Behçet's syndrome.
Leccese, P; Ozguler, Y; Christensen, R; Esatoglu, SN; Bang, D; Bodaghi, B; Celik, AF; Fortune, F; Gaudric, J; Gül, A (2019-02)OBJECTIVES: The aim of this systematic review was to inform the update of European League Against Rheumatism (EULAR) Recommendations for the management of Behçet's syndrome (BS), on the evidence for the treatment of skin, ...